Literature DB >> 519614

Epidemic of mumps in a partially immune population.

J E Lewis, M A Chernesky, M L Rawls, W E Rawls.   

Abstract

The incidence of mumps in vaccinated and nonvaccinated schoolchildren was studied after a recent epidemic. Information was collected by telephone interviews with the parents and a review of the physicians' records. The vaccine appeared to be effective, for the incidence of mumps in the 145 vaccinated children--5.5%, or 8 cases--was significantly less (P less than 0.001) than the incidence in the 350 children considered susceptible to infection--21.7%, or 76 cases. The percentage of children who had been immunized decreased with increasing age, and acquisition of immunity through natural infection had the reverse trend; thus, the proportions of children susceptible to infection in each age group were about the same, and the age-specific attack rates were similar. Although the mothers were accurate in indicating absence of vaccination, they incorrectly indicated vaccination of their children 43.0% of the time; this error in reporting could influence vaccine administration in older children. Our findings suggest that mumps vaccination may substitute for natural illness in immunizing populations, and that more extensive use of the vaccine over a broader age range is required to prevent similar epidemics in the future.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 519614      PMCID: PMC1704254     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  10 in total

1.  Current status of mumps in the United States.

Authors:  A D Bennett; J Modlin; W A Orenstein
Journal:  J Infect Dis       Date:  1975-07       Impact factor: 5.226

2.  Long-term follow-up for immunity after monovalent or combined live measles, mumps, and rubella virus vaccines.

Authors:  R E Weibel; E B Buynak; A A McLean; M R Hilleman
Journal:  Pediatrics       Date:  1975-09       Impact factor: 7.124

3.  A NATIONWIDE SERUM SURVEY OF UNITED STATES MILITARY RECRUITS, 1962. 3. MEASLES AND MUMPS ANTIBODIES.

Authors:  F L BLACK
Journal:  Am J Hyg       Date:  1964-11

4.  Isolation of mumps virus from children with acute lower respiratory tract disease.

Authors:  H M Foy; M K Cooney; C E Hall; E Bor; A J Maletzky
Journal:  Am J Epidemiol       Date:  1971-11       Impact factor: 4.897

5.  Guide to immunization against mumps.

Authors:  A M Lerner
Journal:  J Infect Dis       Date:  1970 Jul-Aug       Impact factor: 5.226

6.  Public acceptance of mumps immunization. Report of one year's experience offering live mumps vaccine in a public health clinic and school immunization program.

Authors:  P H Jones
Journal:  JAMA       Date:  1969-08-11       Impact factor: 56.272

7.  Current status of mumps and mumps vaccine in the United States.

Authors:  G F Hayden; S R Preblud; W A Orenstein; J L Conrad
Journal:  Pediatrics       Date:  1978-12       Impact factor: 7.124

8.  Live attenuated mumps-virus vaccine. 3. Clinical and serologic aspects in a field evaluation.

Authors:  R E Weibel; J Stokes; E B Buynak; J E Whitman; M R Hilleman
Journal:  N Engl J Med       Date:  1967-02-02       Impact factor: 91.245

9.  Live attenuated mumps-virus vaccine. IV. Protective efficacy as measured in a field evaluation.

Authors:  M R Hilleman; R E Weibel; E B Buynak; J Stokes; J E Whitman
Journal:  N Engl J Med       Date:  1967-02-02       Impact factor: 91.245

10.  Analysis of a measles epidemic; possible role of vaccine failures.

Authors:  W E Rawls; M L Rawls; M A Chernesky
Journal:  Can Med Assoc J       Date:  1975-11-22       Impact factor: 8.262

  10 in total
  4 in total

1.  Safety and immunogenicity of a live attenuated mumps vaccine: a phase I clinical trial.

Authors:  Yan Liang; Jingchen Ma; Changgui Li; Yuguo Chen; Longding Liu; Yun Liao; Ying Zhang; Li Jiang; Xuan-Yi Wang; Yanchun Che; Wei Deng; Hong Li; Xiaoyu Cui; Na Ma; Dong Ding; Zhongping Xie; Pingfang Cui; Qiuyan Ji; JingJing Wang; Yuliang Zhao; Junzhi Wang; Qihan Li
Journal:  Hum Vaccin Immunother       Date:  2014-03-10       Impact factor: 3.452

2.  [A look back at 2 mumps outbreaks].

Authors:  M F Paccaud; P Hazeghi; M Bourquin; A M Maurer; C A Steiner; A J Seiler; P Helbling; H Zimmermann
Journal:  Soz Praventivmed       Date:  1995

Review 3.  Knowledge gaps persist and hinder progress in eliminating mumps.

Authors:  R Ramanathan; E A Voigt; R B Kennedy; G A Poland
Journal:  Vaccine       Date:  2018-05-18       Impact factor: 4.169

4.  Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro) and a varicella vaccine (VARIVAX) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial.

Authors:  Yves Gillet; Pirmin Habermehl; Stéphane Thomas; Cécile Eymin; Anne Fiquet
Journal:  BMC Med       Date:  2009-04-14       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.